Sandra Dreike, M.S., CGC

[email protected]
626-218-8662
Sandra Dreike, M.S., CGC
Senior Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research
Clinical Expertise
  • Clinical Cancer Genomics
Clinical Teams
Clinical Cancer Genomics

Sandra Dreike, M.S., CGC, is a licensed, board-certified genetic counselor specializing in cancer genetics. She received her Master of Science in genetic counseling from the University of California Irvine, and her bachelor's in biology from California Polytechnic State University in San Luis Obispo. Dreike joined City of Hope's Division of Clinical Cancer Genomics in 2019. She previously practiced as a genetic counselor in Honolulu, specializing in cancer genetics and general pediatric and adult genetics. Dreike provides genetic counseling and cancer genetic risk assessments at City of Hope. In addition to patient care, she assists with the Intensive Course in Cancer Risk Assessment and is also involved in research. She is a member of the National Society of Genetic Counselors and Southern California Genetic Counselors.

Location

Education & Experience

Degrees
  • 2010, Master of Science, Genetic Counseling, University of California Irvine, Irvine, CA
  • 2006, Bachelor of Science, Biology, California Polytechnic State University, San Luis Obispo, CA
     
Professional Experience
  • 2022-present, Sr. Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, South Pasadena, CA
  • 2019-2022, Cancer Risk Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
  • 2010-2019, Cancer/Adult/Pediatric/Prenatal Genetic Counselor, Hawaii Pacific Health, Honolulu, HI

Awards & Memberships

Memberships

  • 2019, Southern California Genetic Counselors
  • 2011, Board Certified Member, American Board of Genetic Counselors
  • 2009, Member, National Society of Genetic Counselors
  • 2011-2012, Founder and Organizer, Peer Supervision Group for Genetic Counselors 
     

Publications

  • Strauss KA, DuBiner L, Simon M, Zaragoza M, Sengupta PP, Li P, Narula N, Dreike S, Platt J, Procaccio V, Ortiz-Gonzalez XR, Puffenberger EG, Kelley RI, Morton DH, Narula J, Wallace DC. (2013). Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup. Proc Natl Acad Sci USA. 110(9):3453-8. PMID 23401503.